BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alfaifi M, Eom YW, Newsome PN, Baik SK. Mesenchymal stromal cell therapy for liver diseases. J Hepatol. 2018;68:1272-1285. [PMID: 29425678 DOI: 10.1016/j.jhep.2018.01.030] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 15.3] [Reference Citation Analysis]
Number Citing Articles
1 Eiro N, Fraile M, González-jubete A, González LO, Vizoso FJ. Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. IJMS 2022;23:8905. [DOI: 10.3390/ijms23168905] [Reference Citation Analysis]
2 Qin L, Liu N, Bao CL, Yang DZ, Ma GX, Yi WH, Xiao GZ, Cao HL. Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin. Acta Pharmacol Sin 2022. [PMID: 35896695 DOI: 10.1038/s41401-022-00952-0] [Reference Citation Analysis]
3 Yao L, Hu X, Dai K, Yuan M, Liu P, Zhang Q, Jiang Y. Mesenchymal stromal cells: promising treatment for liver cirrhosis. Stem Cell Res Ther 2022;13:308. [PMID: 35841079 DOI: 10.1186/s13287-022-03001-z] [Reference Citation Analysis]
4 Zhang R, Li W, Jiang X, Cui X, You H, Tang Z, Liu W. Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis. Front Pharmacol 2022;13:863797. [PMID: 35721175 DOI: 10.3389/fphar.2022.863797] [Reference Citation Analysis]
5 Liu QW, Ying YM, Zhou JX, Zhang WJ, Liu ZX, Jia BB, Gu HC, Zhao CY, Guan XH, Deng KY, Xin HB. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice. Stem Cell Res Ther 2022;13:224. [PMID: 35659360 DOI: 10.1186/s13287-022-02906-z] [Reference Citation Analysis]
6 Gardin A, Remih K, Gonzales E, Andersson ER, Strnad P. Modern therapeutic approaches to liver-related disorders. J Hepatol 2022;76:1392-409. [PMID: 35589258 DOI: 10.1016/j.jhep.2021.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang J, Huang D, Ren H, Shang L. Biomimic Trained Immunity-MSCs Delivery Microcarriers for Acute Liver Failure Regeneration. Small 2022;:e2200858. [PMID: 35411651 DOI: 10.1002/smll.202200858] [Reference Citation Analysis]
8 Shahrbaf MA, Nouri M, Zarrabi M, Gramignoli R, Vosough M. Extraembryonic Mesenchymal Stromal/Stem Cells in Liver Diseases: A Critical Revision of Promising Advanced Therapy Medicinal Products. Cells 2022;11:1074. [PMID: 35406638 DOI: 10.3390/cells11071074] [Reference Citation Analysis]
9 Liao C, Chen G, Yang Q, Liu Y, Zhou T. Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis. Front Cell Dev Biol 2022;10:824752. [DOI: 10.3389/fcell.2022.824752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liu Q, Lv C, Jiang Y, Luo K, Gao Y, Liu J, Zhang X, Mohammad Omar J, Jin S. From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation. PeerJ 2022;10:e12872. [PMID: 35186473 DOI: 10.7717/peerj.12872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Benić MS, Nežić L, Vujić-Aleksić V, Mititelu-Tartau L. Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review. Front Pharmacol 2021;12:785790. [PMID: 35185538 DOI: 10.3389/fphar.2021.785790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dai Q, Jiang W, Huang F, Song F, Zhang J, Zhao H. Recent Advances in Liver Engineering With Decellularized Scaffold. Front Bioeng Biotechnol 2022;10:831477. [DOI: 10.3389/fbioe.2022.831477] [Reference Citation Analysis]
13 Anand H, Nulty J, Dhawan A. Cell therapy in congenital inherited hepatic disorders. Best Pract Res Clin Gastroenterol 2022;56-57:101772. [PMID: 35331403 DOI: 10.1016/j.bpg.2021.101772] [Reference Citation Analysis]
14 Yang N, Ma W, Ke Y, Liu H, Chu J, Sun L, Lü G, Bi X, Lin R. Transplantation of adipose-derived stem cells ameliorates Echinococcus multilocularis-induced liver fibrosis in mice. PLoS Negl Trop Dis 2022;16:e0010175. [PMID: 35100287 DOI: 10.1371/journal.pntd.0010175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li YH, Shen S, Shao T, Jin MT, Fan DD, Lin AF, Xiang LX, Shao JZ. Mesenchymal stem cells attenuate liver fibrosis by targeting Ly6Chi/lo macrophages through activating the cytokine-paracrine and apoptotic pathways. Cell Death Discov 2021;7:239. [PMID: 34518510 DOI: 10.1038/s41420-021-00584-z] [Reference Citation Analysis]
16 Jindal A, Jagdish RK, Kumar A. Hepatic Regeneration in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.029] [Reference Citation Analysis]
17 Chen L, Qu J, Mei Q, Chen X, Fang Y, Chen L, Li Y, Xiang C. Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine. Stem Cell Res Ther 2021;12:433. [PMID: 34344458 DOI: 10.1186/s13287-021-02511-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Câmara DAD, Porcacchia AS, Lizier NF, De-sá-júnior PL. A COVID-19 Overview and Potential Applications of Cell Therapy. Biologics 2021;1:177-88. [DOI: 10.3390/biologics1020011] [Reference Citation Analysis]
19 Zou D, Wang H, Liu X, Xu ZP, Roberts MS, Zhao CX. Artificial cells for the treatment of liver diseases. Acta Biomater 2021;130:98-114. [PMID: 34126265 DOI: 10.1016/j.actbio.2021.06.012] [Reference Citation Analysis]
20 Amato G, Saleh T, Carpino G, Gaudio E, Alvaro D, Cardinale V. Cell Therapy and Bioengineering in Experimental Liver Regenerative Medicine: In Vivo Injury Models and Grafting Strategies. Curr Transpl Rep 2021;8:76-89. [DOI: 10.1007/s40472-021-00325-2] [Reference Citation Analysis]
21 Yao Y, Xia Z, Cheng F, Jang Q, He J, Pan C, Zhang L, Ye Y, Wang Y, Chen S, Su D, Su X, Cheng L, Shi G, Dai L, Deng H. Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells. Stem Cell Res Ther 2021;12:294. [PMID: 34016164 DOI: 10.1186/s13287-021-02358-x] [Reference Citation Analysis]
22 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver 2020;14:306-15. [PMID: 31581387 DOI: 10.5009/gnl18412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 22.0] [Reference Citation Analysis]
24 Zhang J, Gao J, Lin D, Xiong J, Wang J, Chen J, Lin B, Gao Z. Potential Networks Regulated by MSCs in Acute-On-Chronic Liver Failure: Exosomal miRNAs and Intracellular Target Genes. Front Genet 2021;12:650536. [PMID: 33968135 DOI: 10.3389/fgene.2021.650536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhao J, Li Y, Jia R, Wang J, Shi M, Wang Y. Mesenchymal Stem Cells-Derived Exosomes as Dexamethasone Delivery Vehicles for Autoimmune Hepatitis Therapy. Front Bioeng Biotechnol 2021;9:650376. [PMID: 33859980 DOI: 10.3389/fbioe.2021.650376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fernández-Francos S, Eiro N, Costa LA, Escudero-Cernuda S, Fernández-Sánchez ML, Vizoso FJ. Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine. Int J Mol Sci 2021;22:3576. [PMID: 33808241 DOI: 10.3390/ijms22073576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
27 Khan S, Khan RS, Newsome PN. Cell Therapy for Liver Disease: From Promise to Reality. Semin Liver Dis 2020;40:411-26. [PMID: 33764490 DOI: 10.1055/s-0040-1717096] [Reference Citation Analysis]
28 Eom YW, Yoon Y, Baik SK. Mesenchymal stem cell therapy for liver disease: current status and future perspectives. Curr Opin Gastroenterol 2021;37:216-23. [PMID: 33769377 DOI: 10.1097/MOG.0000000000000724] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Loussouarn C, Pers YM, Bony C, Jorgensen C, Noël D. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Regulate the Mitochondrial Metabolism via Transfer of miRNAs. Front Immunol 2021;12:623973. [PMID: 33796099 DOI: 10.3389/fimmu.2021.623973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Liu Q, Chen X, Liu C, Pan L, Kang X, Li Y, Du C, Dong S, Xiang AP, Xu Y, Zhang Q. Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression. Cell Death Dis 2021;12:240. [PMID: 33664231 DOI: 10.1038/s41419-021-03524-y] [Reference Citation Analysis]
31 Luo H, Li D, Chen Z, Wang B, Chen S. Manufacturing and banking canine adipose-derived mesenchymal stem cells for veterinary clinical application. BMC Vet Res 2021;17:96. [PMID: 33648493 DOI: 10.1186/s12917-021-02791-3] [Reference Citation Analysis]
32 Baig MT, Ghufran H, Mehmood A, Azam M, Humayun S, Riazuddin S. Vitamin E pretreated Wharton's jelly-derived mesenchymal stem cells attenuate CCl4-induced hepatocyte injury in vitro and liver fibrosis in vivo. Biochem Pharmacol 2021;186:114480. [PMID: 33617844 DOI: 10.1016/j.bcp.2021.114480] [Reference Citation Analysis]
33 Aithal AP, Bairy LK, Seetharam RN, Kumar N. Hepatoprotective effect of bone marrow-derived mesenchymal stromal cells in CCl4-induced liver cirrhosis. 3 Biotech 2021;11:107. [PMID: 33564610 DOI: 10.1007/s13205-021-02640-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Wang J, Liu Y, Ding H, Shi X, Ren H. Mesenchymal stem cell-secreted prostaglandin E2 ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization. Stem Cell Res Ther 2021;12:15. [PMID: 33413632 DOI: 10.1186/s13287-020-02070-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Pampalone M, Corrao S, Amico G, Vitale G, Alduino R, Conaldi PG, Pietrosi G. Human Amnion-Derived Mesenchymal Stromal Cells in Cirrhotic Patients with Refractory Ascites: A Possible Anti-Inflammatory Therapy for Preventing Spontaneous Bacterial Peritonitis. Stem Cell Rev Rep 2021;17:981-98. [PMID: 33389680 DOI: 10.1007/s12015-020-10104-8] [Reference Citation Analysis]
36 Kweon M, Kim JY, Jun JH, Kim GJ. Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. Int J Mol Sci 2020;22:E239. [PMID: 33383629 DOI: 10.3390/ijms22010239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Floreani A. Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis. J Exp Pharmacol 2020;12:643-52. [PMID: 33364858 DOI: 10.2147/JEP.S267375] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Al-Dhamin Z, Liu LD, Li DD, Zhang SY, Dong SM, Nan YM. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies. World J Gastroenterol 2020; 26(47): 7444-7469 [PMID: 33384547 DOI: 10.3748/wjg.v26.i47.7444] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Kim J, Lee C, Shin Y, Wang S, Han J, Kim M, Kim JM, Shin SC, Lee BJ, Kim TJ, Jung Y. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Mol Ther 2021;29:1471-86. [PMID: 33348053 DOI: 10.1016/j.ymthe.2020.12.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Khan S, Khan RS, Newsome PN. Cellular therapies for the treatment of immune-mediated GI and liver disease. Br Med Bull 2020;136:127-41. [PMID: 33290518 DOI: 10.1093/bmb/ldaa035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Lim YL, Eom YW, Park SJ, Hong T, Kang SH, Baik SK, Park KS, Kim MY. Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics. Int J Stem Cells 2020;13:394-403. [PMID: 32840228 DOI: 10.15283/ijsc20072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Angioni R, Calì B, Vigneswara V, Crescenzi M, Merino A, Sánchez-Rodríguez R, Liboni C, Hoogduijn MJ, Newsome PN, Muraca M, Russo FP, Viola A. Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice. Int J Mol Sci 2020;21:E8874. [PMID: 33238629 DOI: 10.3390/ijms21228874] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Yin F, Wang W, Mao L, Cai Q, Jiang W. Effect of Human Umbilical Cord Mesenchymal Stem Cells Transfected with HGF on TGF-β1/Smad Signaling Pathway in Carbon Tetrachloride-Induced Liver Fibrosis Rats. Stem Cells and Development 2020;29:1395-406. [DOI: 10.1089/scd.2020.0060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Dwyer BJ, Macmillan MT, Brennan PN, Forbes SJ. Cell therapy for advanced liver diseases: Repair or rebuild. J Hepatol 2021;74:185-99. [PMID: 32976865 DOI: 10.1016/j.jhep.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
45 Hsu MJ, Karkossa I, Schäfer I, Christ M, Kühne H, Schubert K, Rolle-Kampczyk UE, Kalkhof S, Nickel S, Seibel P, von Bergen M, Christ B. Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH. Biomedicines 2020;8:E350. [PMID: 32937969 DOI: 10.3390/biomedicines8090350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Yao X, Wang J, Zhu J, Rong X. The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis. Stem Cell Res Ther 2020;11:379. [PMID: 32883340 DOI: 10.1186/s13287-020-01891-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Häussinger D, Kordes C. Space of Disse: a stem cell niche in the liver. Biol Chem 2019;401:81-95. [PMID: 31318687 DOI: 10.1515/hsz-2019-0283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
48 Ge X, Liu W, Zhao W, Feng S, Duan A, Ji C, Shen K, Liu W, Zhou J, Jiang D, Rong Y, Gong F, Wang J, Xu Z, Li X, Fan J, Wei Y, Bai J, Cai W. Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway. Mol Ther Nucleic Acids 2020;21:900-15. [PMID: 32810692 DOI: 10.1016/j.omtn.2020.07.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
49 Li M, Jiang M, Meng J, Tao L. Exosomes: Carriers of Pro-Fibrotic Signals and Therapeutic Targets in Fibrosis. Curr Pharm Des 2019;25:4496-509. [PMID: 31814552 DOI: 10.2174/1381612825666191209161443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
50 Wang J, Fu X, Yan Y, Li S, Duan Y, Marie Inglis B, Si W, Zheng B. In vitro differentiation of rhesus macaque bone marrow- and adipose tissue-derived MSCs into hepatocyte-like cells. Exp Ther Med 2020;20:251-60. [PMID: 32518605 DOI: 10.3892/etm.2020.8676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Lv Y, So KF, Xiao J. Liver regeneration and alcoholic liver disease. Ann Transl Med 2020;8:567. [PMID: 32775368 DOI: 10.21037/atm.2020.02.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Li S, Feng X, Cao G, Wang Q, Wang L. Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis. PLoS One 2020;15:e0230879. [PMID: 32214401 DOI: 10.1371/journal.pone.0230879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
53 Yang F, Medik Y, Li L, Tian X, Fu D, Brouwer KLR, Wagner K, Sun B, Sendi H, Mi Y, Wang AZ. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo. Small 2020;16:e1906360. [PMID: 31972070 DOI: 10.1002/smll.201906360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
54 Feng Y, Wang AT, Jia HH, Zhao M, Yu H. A Brief Analysis of Mesenchymal Stem Cells as Biological Drugs for the Treatment of Acute-on-Chronic Liver Failure (ACLF): Safety and Potency. Curr Stem Cell Res Ther 2020;15:202-10. [PMID: 31893994 DOI: 10.2174/1574888X15666200101124317] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Wang M, Zhang M, Fu L, Lin J, Zhou X, Zhou P, Huang P, Hu H, Han Y. Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis. Theranostics 2020;10:36-49. [PMID: 31903104 DOI: 10.7150/thno.37301] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
56 Fang J, Yan Y, Teng X, Wen X, Li N, Peng S, Liu W, Donadeu FX, Zhao S, Hua J. Melatonin prevents senescence of canine adipose-derived mesenchymal stem cells through activating NRF2 and inhibiting ER stress. Aging (Albany NY). 2018;10:2954-2972. [PMID: 30362962 DOI: 10.18632/aging.101602] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
57 Dai X, Yan X, Wintergerst KA, Cai L, Keller BB, Tan Y. Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function. Trends Mol Med. 2020;26:185-200. [PMID: 31679988 DOI: 10.1016/j.molmed.2019.09.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
58 Kim JY, Jun JH, Park SY, Yang SW, Bae SH, Kim GJ. Dynamic Regulation of miRNA Expression by Functionally Enhanced Placental Mesenchymal Stem Cells PromotesHepatic Regeneration in a Rat Model with Bile Duct Ligation. Int J Mol Sci 2019;20:E5299. [PMID: 31653075 DOI: 10.3390/ijms20215299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
59 Kholodenko IV, Kurbatov LK, Kholodenko RV, Manukyan GV, Yarygin KN. Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope? Cells 2019;8:E1127. [PMID: 31546729 DOI: 10.3390/cells8101127] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
60 Wang HY, Li C, Liu WH, Deng FM, Ma Y, Guo LN, Kong H, Hu KA, Liu Q, Wu J, Sun J, Liu YL. Autophagy inhibition via Becn1 downregulation improves the mesenchymal stem cells antifibrotic potential in experimental liver fibrosis. J Cell Physiol. 2020;235:2722-2737. [PMID: 31508820 DOI: 10.1002/jcp.29176] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
61 Rong X, Yang Y, Zhang G, Zhang H, Li C, Wang Y. Antler stem cells as a novel stem cell source for reducing liver fibrosis. Cell Tissue Res 2020;379:195-206. [PMID: 31428875 DOI: 10.1007/s00441-019-03081-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
62 Driscoll J, Patel T. The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease. J Gastroenterol. 2019;54:763-773. [PMID: 31270691 DOI: 10.1007/s00535-019-01599-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
63 van der Helm D, Barnhoorn MC, de Jonge-Muller ESM, Molendijk I, Hawinkels LJAC, Coenraad MJ, van Hoek B, Verspaget HW. Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers. J Cell Mol Med 2019;23:6238-50. [PMID: 31245923 DOI: 10.1111/jcmm.14508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
64 Gupta H, Youn GS, Han SH, Shin MJ, Yoon SJ, Han DH, Lee NY, Kim DJ, Baik SK, Suk KT. Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis. J Clin Med 2019;8:E862. [PMID: 31212896 DOI: 10.3390/jcm8060862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Wang X, Jiao Y, Pan Y, Zhang L, Gong H, Qi Y, Wang M, Shao M, Wang X, Jiang D. Fetal Dermal Mesenchymal Stem Cell-Derived Exosomes Accelerate Cutaneous Wound Healing by Activating Notch Signaling. Stem Cells Int. 2019;2019:2402916. [PMID: 31281370 DOI: 10.1155/2019/2402916] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
66 Yamazaki T, Kishimoto T, Leszczyński P, Sadakane K, Kenmotsu T, Watanabe H, Kazama T, Matsumoto T, Yoshikawa K, Taniguchi H. Construction of 3D Cellular Composites with Stem Cells Derived from Adipose Tissue and Endothelial Cells by Use of Optical Tweezers in a Natural Polymer Solution. Materials (Basel) 2019;12:E1759. [PMID: 31151204 DOI: 10.3390/ma12111759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Chinnadurai R, Sands J, Rajan D, Liu X, Arafat D, Das R, Anania FA, Gibson G, Kisseleva T, Galipeau J. Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate Cells. Stem Cells 2019;37:1075-82. [PMID: 31033095 DOI: 10.1002/stem.3028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
68 Itaba N, Kono Y, Watanabe K, Yokobata T, Oka H, Osaki M, Kakuta H, Morimoto M, Shiota G. Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets. Sci Rep. 2019;9:6841. [PMID: 31048740 DOI: 10.1038/s41598-019-43298-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
69 Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem Cell Res Ther 2019;10:98. [PMID: 30885249 DOI: 10.1186/s13287-019-1204-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 21.3] [Reference Citation Analysis]
70 Yang L, Dong C, Yang J, Yang L, Chang N, Qi C, Li L. MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta. Mol Ther Nucleic Acids. 2019;16:206-217. [PMID: 30901579 DOI: 10.1016/j.omtn.2019.02.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
71 Zhang T, Chen H, Zhang Y, Zan Y, Ni T, Liu M, Pei R. Osteogenic differentiation of BMSCs in collagen-based 3D scaffolds. New J Chem 2019;43:1980-6. [DOI: 10.1039/c8nj04100h] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 van der Helm D, Groenewoud A, de Jonge-Muller ESM, Barnhoorn MC, Schoonderwoerd MJA, Coenraad MJ, Hawinkels LJAC, Snaar-Jagalska BE, van Hoek B, Verspaget HW. Mesenchymal stromal cells prevent progression of liver fibrosis in a novel zebrafish embryo model. Sci Rep 2018;8:16005. [PMID: 30375438 DOI: 10.1038/s41598-018-34351-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
73 Liu Y, Ren H, Wang J, Yang F, Li J, Zhou Y, Yuan X, Zhu W, Shi X. Prostaglandin E2 secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation. FASEB J 2019;33:2514-25. [PMID: 30260707 DOI: 10.1096/fj.201801349RR] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
74 Zhang S, Wan H, Wang P, Liu M, Li G, Zhang C, Sun Y. Extracellular matrix protein DMP1 suppresses osteogenic differentiation of Mesenchymal Stem Cells. Biochem Biophys Res Commun 2018;501:968-73. [PMID: 29775615 DOI: 10.1016/j.bbrc.2018.05.092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]